Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inherited polycythemia].

M Pavic1, H Rousset

  • 1Service de médecine interne, hôpital Desgenettes, 108, boulevard Pinel, 69003 Lyon, France. mpavic@club-internet.fr

La Revue De Medecine Interne
|July 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2023
Same author

The impact of subjective image quality evaluation in mammography.

Radiography (London, England : 1995)·2023
Same author

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.

Frontiers in oncology·2022
Same author

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

ESMO open·2022
Same author

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).

Radiation oncology (London, England)·2022
Same author

Patterns of integrating palliative care into standard oncology in an early ESMO designated center: a 10-year experience.

ESMO open·2021
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Inherited polycythemias are rare, with most cases occurring sporadically. Recent discoveries, like the erythropoietin receptor gene mutation, are explaining some primary familial and congenital polycythemias.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Context:

  • Polycythemia, characterized by elevated red blood cell mass, can be sporadic or familial.
  • While some forms linked to hemoglobin oxygen affinity are understood, primary polycythemias have only recently begun to be explained.
  • The erythropoietin receptor gene mutation is a key discovery in understanding these conditions.

Purpose:

  • To review current knowledge on inherited polycythemias.
  • To highlight the genetic basis of familial and congenital polycythemias.
  • To discuss the evolving understanding of polycythemia etiology.

Summary:

  • Most polycythemias are sporadic; familial cases are uncommon.
  • Inherited polycythemias are increasingly understood due to genetic discoveries.

Related Experiment Videos

  • Erythropoietin receptor gene mutations explain some primary familial and congenital polycythemias.

    • Impact:

    • Advances in understanding inherited polycythemias are reducing the proportion of idiopathic cases.
    • Genetic insights are crucial for diagnosing and potentially treating familial polycythemias.
    • Continued research is needed for unresolved cases like Chuvash polycythemia.